News

Researchers have shown that changing the dose and route of administration greatly increases the ability of the TB vaccine to protect rhesus macaques from infection.

The ISLET project, a multi-center collaboration of leading European researchers, aims to develop a manufacturing pipeline for stem cell-based products to treat patients with Type 1 Diabetes.

Researchers have developed a novel way to record a patient’s vaccination history: storing the data in a pattern of dye, invisible to the naked eye, that is delivered under the skin at the same time as the vaccine.

Researchers have discovered a way to supercharge protein production up to a thousandfold. The findings could help increase production and drive down costs of making certain protein-based drugs, vaccines and diagnostics, as well as proteins used in the food, agriculture, biomaterials, bioenergy and chemical industries.

A research team led by NTU Professor Gerhard Grüber has discovered how a compound, known as epigallocatechin gallate (EGCG), can inhibit the growth of a tuberculosis-causing bacterium.

Researchers are helping usher in a new age of cardiac pacemakers by using stem cells found in fat, converting them to heart cells, and reprogramming those to act as biologic pacemaker cells.

Scientists have established a new gene-therapy technique, by transforming human cells into mass producers of tiny nano-sized particles full of genetic material.

A research team led by Andrés Valderrama at UC San Diego School of Medicine and Surashree Kulkarni of the Division of Biological Sciences has developed a new CRISPR-based gene-drive system that dramatically increases the efficiency of inactivating a gene rendering bacteria antibiotic-resistant.

Microbes living in the rectum could make a difference to the effectiveness of experimental HIV vaccines.

The surprising role of an immune cell that explains some of biologic drugs' side effects could lead to better treatments for persistent infections and cancer.